| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.0097 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.01 | 1 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |